J. Galleshaw

694 total citations
11 papers, 574 citations indexed

About

J. Galleshaw is a scholar working on Cancer Research, Oncology and Genetics. According to data from OpenAlex, J. Galleshaw has authored 11 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 5 papers in Oncology and 5 papers in Genetics. Recurrent topics in J. Galleshaw's work include Breast Cancer Treatment Studies (6 papers), Advanced Breast Cancer Therapies (4 papers) and Estrogen and related hormone effects (3 papers). J. Galleshaw is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), Advanced Breast Cancer Therapies (4 papers) and Estrogen and related hormone effects (3 papers). J. Galleshaw collaborates with scholars based in United States, Netherlands and Ireland. J. Galleshaw's co-authors include A Ríos, Bruce J. Dezube, H Jablonowski, Keikawus Arastéh, F. D. Goebel, Sherry H. Stewart, David M. Aboulafia, M.F. Spittle, Inder M. Verma and Charles Van Beveren and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Cancer.

In The Last Decade

J. Galleshaw

10 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Galleshaw United States 6 311 177 138 92 75 11 574
Anna Merlo Italy 17 384 1.2× 332 1.9× 75 0.5× 90 1.0× 115 1.5× 32 825
Michael A. Goldenhersh Israel 14 271 0.9× 107 0.6× 78 0.6× 69 0.8× 22 0.3× 26 626
Tomas Lindahl Sweden 13 539 1.7× 206 1.2× 196 1.4× 72 0.8× 46 0.6× 18 894
Heiner Frost Switzerland 15 145 0.5× 253 1.4× 75 0.5× 38 0.4× 22 0.3× 29 972
John Copier United Kingdom 15 270 0.9× 379 2.1× 85 0.6× 60 0.7× 52 0.7× 29 902
Narendiran Rajasekaran United States 12 170 0.5× 154 0.9× 39 0.3× 78 0.8× 64 0.9× 40 531
Sreenivasulu Gunti United States 8 222 0.7× 163 0.9× 115 0.8× 45 0.5× 57 0.8× 16 685
Vanessa G. Oliveira Portugal 13 121 0.4× 182 1.0× 45 0.3× 50 0.5× 20 0.3× 17 1.1k
Bharat Bajaj United States 14 271 0.9× 204 1.2× 73 0.5× 97 1.1× 18 0.2× 19 529
Bernard Clausse France 11 403 1.3× 192 1.1× 138 1.0× 24 0.3× 130 1.7× 13 599

Countries citing papers authored by J. Galleshaw

Since Specialization
Citations

This map shows the geographic impact of J. Galleshaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Galleshaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Galleshaw more than expected).

Fields of papers citing papers by J. Galleshaw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Galleshaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Galleshaw. The network helps show where J. Galleshaw may publish in the future.

Co-authorship network of co-authors of J. Galleshaw

This figure shows the co-authorship network connecting the top 25 collaborators of J. Galleshaw. A scholar is included among the top collaborators of J. Galleshaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Galleshaw. J. Galleshaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Forero‐Torres, Andres, Mansoor N. Saleh, J. Galleshaw, et al.. (2010). Pilot Trial of Preoperative (Neoadjuvant) Letrozole in Combination With Bevacizumab in Postmenopausal Women With Newly Diagnosed Estrogen Receptor— or Progesterone Receptor—Positive Breast Cancer. Clinical Breast Cancer. 10(4). 275–280. 29 indexed citations
2.
3.
Forero, Andres, Mansoor N. Saleh, J. Galleshaw, et al.. (2009). A Pilot Trial of Pre-Operative (Neoadjuvant) Letrozole in Combination with Bevacizumab in Post-Menopausal Women with Newly Diagnosed Estrogen and/or Progesterone Receptor Positive Breast Cancer.. Cancer Research. 69(24_Supplement). 1088–1088. 2 indexed citations
4.
Forero‐Torres, Andres, J. Galleshaw, Caroline E. Jones, et al.. (2008). A pilot open-label trial of preoperative (neoadjuvant) letrozole in combination with bevacizumab in postmenopausal women with newly diagnosed operable breast cancer. Journal of Clinical Oncology. 26(15_suppl). 625–625. 8 indexed citations
5.
Forero‐Torres, Andres, Ivor Percent, J. Galleshaw, et al.. (2007). A study of pre-operative (neoadjuvant) letrozole in combination with bevacizumab in post-menopausal women with newly diagnosed operable breast cancer: A preliminary safety report. Journal of Clinical Oncology. 25(18_suppl). 11020–11020. 2 indexed citations
6.
7.
Kute, Timothy E., Hyman B. Muss, M. Robert Cooper, et al.. (1990). The use of flow cytometry for the prognosis of stage II adjuvant treated breast cancer patients. Cancer. 66(8). 1810–1816. 35 indexed citations
8.
Gregory, B., et al.. (1988). Buss D. Case D How reproducible are flow cytometry data from paraffin embedded blocks. 2 indexed citations
9.
Kute, Timothy E., et al.. (1988). How reproducible are flow cytometry data from paraffin‐embedded blocks?. Cytometry. 9(5). 494–498. 37 indexed citations
10.
Bockstahler, Larry E., C. David Lytle, A. S. Lubiniecki, John Cantwell, & J. Galleshaw. (1982). Mutagenic virus replication in human tumor cells. Cancer Letters. 17(2). 141–145. 1 indexed citations
11.
Beveren, Charles Van, J. Galleshaw, Vivian Jonas, et al.. (1981). Nucleotide sequence and formation of the transforming gene of a mouse sarcoma virus. Nature. 289(5795). 258–262. 182 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Merlo Breakdown of academic impact, for papers by Michael A. Goldenhersh Breakdown of academic impact, for papers by Tomas Lindahl Breakdown of academic impact, for papers by Heiner Frost Breakdown of academic impact, for papers by John Copier Breakdown of academic impact, for papers by Narendiran Rajasekaran Breakdown of academic impact, for papers by Sreenivasulu Gunti Breakdown of academic impact, for papers by Vanessa G. Oliveira Breakdown of academic impact, for papers by Bharat Bajaj Breakdown of academic impact, for papers by Bernard Clausse
Rankless by CCL
2026